George Rudy
Plus aucun poste en cours
Profil
George Rudy is Chief Medical Officer of Akonni Biosystems, Inc. Prior to joining Akonni Biosystems in June 2007, he was Director of Medical and Scientific Affairs for Prosetta Corp., Scientific Director of GeneType Pty.
Ltd., and a Senior Research Scientist at the Walter and Eliza Hall Institute of Medical Research.
He has experience in the fields of tuberculosis control, tropical, infectious diseases, and clinical diabetes care.
Dr. Rudy received a BA degree from Yale University, an MD from Stanford University, and a PhD from the Walter and Eliza Hall Institute of Medical Research.
Anciens postes connus de George Rudy
| Sociétés | Poste | Fin |
|---|---|---|
The Walter & Eliza Hall Institute of Medical Research
 The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
Prosetta Biosciences, Inc.
 Prosetta Biosciences, Inc. BiotechnologyHealth Technology Prosetta Biosciences, Inc. operates as a biopharmaceutical company. Its products include antiviral therapies. The company was founded by Vishwanath R. Lingappa, Jaisri R. Lingappa and David E. Bartlett in 2002 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
| GeneType Pty Ltd | Directeur Technique/Scientifique/R&D | - |
Akonni Biosystems, Inc.
 Akonni Biosystems, Inc. Medical SpecialtiesHealth Technology Akonni Biosystems, Inc. manufactures and sells diagnostic products. The firm's offers sample prep, molecular diagnostics and specialized equipment including TruTip nucleic acid purification kits and automated workstation, TruDiagnosis and TruDx 2000 and TruDx 3000. The company was founded Charles E. Daitch in 2003 and is headquartered in Frederick, MD. | Directeur Technique/Scientifique/R&D | - |
Formation de George Rudy
| Yale University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Akonni Biosystems, Inc.
Akonni Biosystems, Inc. Medical SpecialtiesHealth Technology Akonni Biosystems, Inc. manufactures and sells diagnostic products. The firm's offers sample prep, molecular diagnostics and specialized equipment including TruTip nucleic acid purification kits and automated workstation, TruDiagnosis and TruDx 2000 and TruDx 3000. The company was founded Charles E. Daitch in 2003 and is headquartered in Frederick, MD. | Health Technology |
Prosetta Biosciences, Inc.
Prosetta Biosciences, Inc. BiotechnologyHealth Technology Prosetta Biosciences, Inc. operates as a biopharmaceutical company. Its products include antiviral therapies. The company was founded by Vishwanath R. Lingappa, Jaisri R. Lingappa and David E. Bartlett in 2002 and is headquartered in San Francisco, CA. | Health Technology |
| GeneType Pty Ltd | |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
